ExchangeDEX+
Buy CryptoMarketsSpotFuturesGOLDEarnEvent Center
More
Commodity Zero-Fee Gala
Attendees celebrated the accomplishments of a 10-year collaboration leading to the first patients treated in 2025 The first clinical trial at the HUS BNCT facilityAttendees celebrated the accomplishments of a 10-year collaboration leading to the first patients treated in 2025 The first clinical trial at the HUS BNCT facility

Neutron Therapeutics and Helsinki University Hospital Hold Ribbon Cutting Ceremony for Europe’s first In-Hospital Boron Neutron Capture Therapy Facility

Author: AI Journal
Source: AI Journal
2026/02/13 02:46
3 min read
  • Attendees celebrated the accomplishments of a 10-year collaboration leading to the first patients treated in 2025
  • The first clinical trial at the HUS BNCT facility is nearing completion

HELSINKI and BOSTON, Feb. 12, 2026 /PRNewswire/ — Neutron Therapeutics LLC (NT) and the Helsinki University Hospital (HUS) celebrated the opening of their accelerator-based Boron Neutron Capture Therapy facility. The first-of-its kind facility has been treating patients since May of 2025. HUS organized this event to recognize the accomplishments of the clinical and development teams that made the center a reality. 

The ceremony was attended by Kaisa Juuso, Finnish minster of Social Affairs for Finland, as well as Matti Bergendahl, CEO of HUS, and Bill Buckley, co-founder and majority shareholder of Neutron Therapeutics. Speaking at the ceremony, Mr. Buckley remarked: “With BNCT we saw an opportunity to use our technology to help people with cancer. I’m very proud of what we’ve been able to accomplish here together with HUS.”

Nine patients have been treated at the facility so far, as part of a ten-patient study aimed at demonstrating the safety of BNCT for locally recurrent head and neck cancer using Neutron Therapeutics’ nuBeam® device. nuBeam® is a compact accelerator-based, high-throughput clinical neutron irradiation system specifically designed for BNCT. The device is used in combination with a boron-carrying compound called boronophenylalenine (BPA), which is prepared at HUS. The Comprehensive Cancer Center at HUS is the first European facility to boast an accelerator-based BNCT system.

BNCT is an approved cancer therapy in Japan and is the subject of clinical research in China, Korea, Taiwan and now Finland. BNCT is a tumor-cell-targeted radiation therapy in which neutrons activate a boron-bearing compound that is selectively taken up by tumors. The boron-neutron reaction generates high-energy alpha particles within tumor cells, destroying them while sparing adjacent healthy tissues. The biologically targeted nature of BNCT has the potential to minimize side effects by achieving unmatched conformality of the delivered dose to the tumor. In contrast to treatments like traditional photon or proton radiation therapy or chemotherapy, BNCT is administered in just one or two sessions, making it efficient for the hospital and less taxing for the patient. 

About Helsinki University Hospital

Helsinki University Hospital is a pioneer in the clinical use of BNCT. Before building the present BNCT facility, the hospital has applied BNCT to over 200 cancer patients using a research nuclear reactor as a neutron source. With Neutron Therapeutics’ nuBeam® Suite, Helsinki University Hospital is continuing its leadership in developing clinical applications for many cancer indications.

About Neutron Therapeutics

Neutron Therapeutics is a leading provider of boron neutron capture therapy (BNCT) systems for use in the radiation treatment of cancer patients. Neutron Therapeutics’ nuBeam® Suite, is an accelerator-based, in-hospital neutron source that replaces the previously required nuclear reactor. nuBeam® has the highest flux of all BNCT systems and provides superior beam quality according to guidelines established by the IAEA for the clinical use of neutrons.

Contact: inquiries@nt-bnct.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/neutron-therapeutics-and-helsinki-university-hospital-hold-ribbon-cutting-ceremony-for-europes-first-in-hospital-boron-neutron-capture-therapy-facility-302686774.html

SOURCE Neutron Therapeutics

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Siren Token Sheds 16.4% After 54% Retreat From All-Time High

Siren Token Sheds 16.4% After 54% Retreat From All-Time High

Siren token experienced a sharp 16.4% decline in the past 24 hours, trading at $0.247 as the market cap contracted by $34.4 million. Our analysis of on-chain metrics
Share
Blockchainmagazine2026/03/02 05:03
Privacy is ‘Constant Battle’ Between Blockchain Stakeholders and State

Privacy is ‘Constant Battle’ Between Blockchain Stakeholders and State

The post Privacy is ‘Constant Battle’ Between Blockchain Stakeholders and State appeared on BitcoinEthereumNews.com. Blockchain industry participants and regulators continue wrangling over privacy rights as the European Union’s sweeping Anti-Money Laundering (AML) rules look set to ban privacy-preserving tokens and anonymous crypto accounts starting in 2027. Credit institutions, financial institutions and crypto asset service providers (CASPs) will be prohibited from maintaining anonymous accounts or handling privacy-preserving cryptocurrencies under the EU’s new Anti-Money Laundering Regulation (AMLR) that will go into effect in 2027, Cointelegraph reported in May. Maintaining the right to access privacy-preserving coins like Monero (XMR) has been a “constant battle” between blockchain industry stakeholders and regulators, according to Anja Blaj, an independent legal consultant and policy expert at the European Crypto Initiative. “Once you think of how the states want to play out their policies, they want to establish control. They want to understand who the parties are that transact among themselves,” said Blaj, speaking during Cointelegraph’s daily live X spaces show on Sept. 3. “[The state] wants to understand that to be able to prevent whatever crime and scamming is happening, and we want to enforce the policies that we create as a society.” Her comments came as the EU ramped up its regulatory oversight of the crypto industry, building on the bloc’s Markets in Crypto-Assets Regulation (MiCA). Related: Swiss banks complete first blockchain-based legally binding payment Room for negotiation remains While the AML framework is final, regulatory experts still see potential for negotiation until it rolls out in 2027. Policymaking is a “continuous conversation,” meaning that “nothing is set in stone, even if the regulation is already out,” said Blaj. “There are still ways to either talk to the regulators, see how it’s going to play out, how it’s going to be enforced.” While there’s always room for negotiations with policymakers, the regulation concerning privacy-preserving cryptocurrencies and accounts is becoming “more…
Share
BitcoinEthereumNews2025/09/18 12:45
Santander’s Openbank Enables Bitcoin, Litecoin, POL, Ethereum, and Altcoin Trading for German Customers

Santander’s Openbank Enables Bitcoin, Litecoin, POL, Ethereum, and Altcoin Trading for German Customers

Santander’s digital bank has launched crypto trading in Germany, letting customers buy, sell, and hold these assets. At launch, Openbank customers in Germany can get their hands on Bitcoin, Ethereum, Cardano, Litecoin, and Polygon. Openbank, the digital arm of Banco Santander, has just rolled out a new crypto trading service for its retail customers in [...]]]>
Share
Crypto News Flash2025/09/18 04:00